BroadOak is a founding sponsor of BioTools Innovator, the premier accelerator for life sciences research tools companies. Based in Los Angeles, California, BioTools Innovator matches industry leaders with innovative early-stage and emerging growth biotechnology-focused companies for mentorship and support.
Many early-stage companies have an excellent team and ideas, but lack the experience needed to execute their vision and the funding to fuel growth. BroadOak, and others, provide mentorship free-of-charge to BioTools Innovator companies. After several months of working together, this level of focus and support helps set up BioTools Innovator companies for long term success.
BioTools Innovator’s mission is to “improve human health by accelerating the growth of life science tools and diagnostics companies.” The program provides early-stage life sciences companies with educational materials, networking opportunities, exposure to key stakeholders in the life sciences industry, and the opportunity to receive funding and mentorship.
Learn more here if you’re interested in BioTools Innovator.
The inaugural BioTools Innovator competition received over 160 applicants. 23 companies pitched judges on the BioTools Innovator Road Tour. Ten were selected as finalists and received one-on-one coaching during the months leading up to the final competition.
Machine Bio, a biotech company based in Claremont, California, that offers unique protein synthesis and purification solutions, was the winner of BioTools Innovator’s 2021 cash Grand Prize.
“It was an honor to judge the first BioTools Innovator grand prize competition, and I am thrilled to recognize Machine Bio as the program’s winner,” said BroadOak Partner Bill Snider. “The competition was a reminder of the consistent flow of breakthrough life science innovation out there and we look forward to watching Machine Bio advance their product towards commercialization and adoption. BroadOak is a proud supporter of the BioTools program, and we are excited to continue to support this program that helps accelerate early-stage life science companies who are developing products that advance biomedical research.”
Runner-up companies, including Celldom, Clara Biotech, EpiCypher, and Glyphic Biotechnologies also received cash prizes.
Accellix is benefiting from the BroadOak team’s deep industry expertise, high engagement, and constant availability to advise us on strategic matters. From a transaction perspective, BroadOak has tailored a structure to meet our needs.
CEO | Accellix
We invest in and advise life sciences companies with a focus on Cell and Gene Therapy, Single Cell Genomics, and Life Sciences Software.